Personalized Therapeutic Response
Proteomika is focused on monitoring and predicting personalized therapeutic responses, ensuring tailored care for each patient.
Company background
Founded in 2002, Proteomika is a biotechnology company that is part of the Progenika group
Specialization
Proteomika specializes in developing diagnostic tests for complex diseases, addressing the unique challenges of personalized medicine.
Mission
The company's mission is to equip the medical community with tools for non-invasive diagnosis, monitoring, and prediction of patient responses on an individual basis.
Technological Innovation
Progenika and Proteomika have developed proprietary technologies, including DNA and protein/antibody microarrays, for diagnosing and prognosing various human diseases.
Headquarters
Progenika's headquarters are located in the Bizkaia Technology Park near Bilbao, Spain, with state-of-the-art facilities.
Team and Facilities
We use only top-quality reagents and equipment. We ensure that you receive the best quality available on the market at the best price. All our analyses come with a one-year guarantee.
Vision
Proteomika, in collaboration with Progenika, aims to be a leader in European "post-genomic" research, driven by innovation and excellence.